Oudom Kour

Statistics

Publications

Citations

H-Index

Active since

2023

Affiliations

Washington University in St. Louis(Current)

University of North Carolina at Chapel Hill

Atrium Health Wake Forest Baptist

Wake Forest Baptist Comprehensive Cancer Center

University of Chicago

Oudom Kour is an author at Washington University in St. Louis specializing in oncology, blinatumomab therapy, and b-cell acute lymphoblastic leukemia.

Publications per year

2023–2023

Publications

Chemotherapy-free treatment with inotuzumab ozogamicin and blinatumomab for older adults with newly diagnosed, Ph-negative, CD22-positive, B-cell acute lymphoblastic leukemia: Alliance A041703.

Matthew J. Wieduwilt, Jun Yin, Oudom Kour et al. · Journal of Clinical Oncology · 2023 · 48 citations

Medicine, Hematology, Oncology +13

S117: CHEMOTHERAPY-FREE TREATMENT WITH INOTUZUMAB OZOGAMICIN AND BLINATUMOMAB FOR OLDER ADULTS WITH NEWLY-DIAGNOSED, PH-NEGATIVE, CD22-POSITIVE, B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: ALLIANCE A041703

Matthew J. Wieduwilt, Jun Yin, Oudom Kour et al. · HemaSphere · 2023 · 13 citations · Full text

Medicine, Oncology, Pharmacology +14

1–2 of 2